Patent: 8,142,782
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 8,142,782
| Title: | EGFR inhibitors promote axon regeneration |
| Abstract: | Compositions and methods for promoting neural regeneration in a patient determined to have a lesion in a mature CNS neuron are disclosed. The method comprises the step of contacting the neuron with an EGFR inhibitor sufficient to promote regeneration of the neuron. |
| Inventor(s): | He; Zhigang (Wellesley, MA), Koprivica; Vuk (Bethesda, MD) |
| Assignee: | Children\'s Medical Center Corporation (Boston, MA) |
| Application Number: | 12/372,988 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,142,782
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2025-07-12 |
| Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2025-07-12 |
| Amgen, Inc. | VECTIBIX | panitumumab | Injection | 125147 | 09/27/2006 | ⤷ Try a Trial | 2025-07-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
